Bortezomib No Longer Available Phase 2 Trials for Multiple Myeloma (MM)

IndicationsStatusPurposePhase
No Longer AvailableNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT00063791A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE